HomeCANCER

CANCER

First Cancer TCR Cell Therapy Approved by FDA

August 27, 2024, ...

A “Gutsy” Approach to Predict Immunotherapy Responses  | Blog

A recent study suggests that the bacteria in a patient’s gastrointestinal tract—i.e., the gut microbiome—could help clinicians make more informed decisions about immune...

Even I Am Bored Now!

There, I’ve said it, and I feel ashamed to admit it. I’m even bored of my own regime. 17 years attempting...

Broadening Clinical Trial Eligibility: A Tricky Balancing Act  | Blog

The scientific method is rooted in the careful control of materials, variables, and procedures. Any deviations between experimental groups may introduce bias that...

Hot Topics